Compare SXTP & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SXTP | SPRC |
|---|---|---|
| Founded | 2010 | 2004 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0M | 3.3M |
| IPO Year | 2023 | 2014 |
| Metric | SXTP | SPRC |
|---|---|---|
| Price | $1.06 | $6.62 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $14.10 | N/A |
| AVG Volume (30 Days) | 78.3K | ★ 420.7K |
| Earning Date | 05-15-2026 | 04-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 36.77 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,005,471.00 | N/A |
| Revenue This Year | $33.92 | N/A |
| Revenue Next Year | $51.35 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 65.49 | N/A |
| 52 Week Low | $0.34 | $0.46 |
| 52 Week High | $8.62 | $15.79 |
| Indicator | SXTP | SPRC |
|---|---|---|
| Relative Strength Index (RSI) | 35.82 | 51.63 |
| Support Level | $1.05 | $5.86 |
| Resistance Level | $1.12 | $7.60 |
| Average True Range (ATR) | 0.09 | 0.52 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 24.00 | 45.98 |
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two operating reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.